🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of acetaminophen, alleging the firms concealed alleged dangers that the drug presented to pediatric neurological development.

The lawsuit follows four weeks after President Donald Trump advocated an unsubstantiated connection between using Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "deceived the public by gaining financially from pain and marketing drugs regardless of the potential hazards."

Kenvue asserts there is lacking scientific proof tying Tylenol to autism.

"These manufacturers deceived for years, intentionally threatening millions to increase profits," the attorney general, a Republican, declared.

The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the possible consequences that could have on the health of American women and children."

On its website, the company also said it had "consistently assessed the pertinent research and there is insufficient valid information that demonstrates a verified association between using paracetamol and autism spectrum disorder."

Associations speaking for doctors and healthcare providers concur.

The leading OB-GYN organization has stated acetaminophen - the primary component in Tylenol - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of studies on the use of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the consumption of paracetamol in any period of pregnancy results in neurodevelopmental disorders in children," the group stated.

This legal action cites current declarations from the former administration in asserting the drug is reportedly hazardous.

Recently, Trump raised alarms from medical authorities when he told expectant mothers to "struggle intensely" not to use acetaminophen when ill.

The FDA then issued a notice that physicians should think about restricting the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had vowed in April to initiate "extensive scientific investigation" that would identify the source of autism in a short period.

But authorities warned that finding a single cause of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that influences how persons experience and engage with the environment, and is recognized using medical professional evaluations.

In his lawsuit, the attorney general - who supports Trump who is seeking the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

This legal action aims to force the corporations "destroy any commercial messaging" that claims Tylenol is reliable for expectant mothers.

This legal action parallels the complaints of a group of guardians of children with autism and ADHD who filed suit against the makers of Tylenol in recently.

The court dismissed the case, stating studies from the parents' expert witnesses was inconclusive.